HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David P Molkentine Selected Research
David P Molkentine Research Topics
Disease
12
Neoplasms (Cancer)
01/2022 - 11/2009
9
Squamous Cell Carcinoma of Head and Neck
01/2021 - 04/2011
5
Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 04/2011
2
Carcinoma (Carcinomatosis)
01/2017 - 11/2012
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1
Necrosis
01/2019
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1
Lymphatic Metastasis
04/2011
1
Lymphoma (Lymphomas)
11/2009
1
Pancreatic Neoplasms (Pancreatic Cancer)
11/2009
Drug/Important Bio-Agent (IBA)
3
ErbB Receptors (EGF Receptor)
IBA
01/2015 - 04/2011
2
Protons (Proton)
IBA
01/2019 - 01/2017
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 04/2011
2
Biomarkers (Surrogate Marker)
IBA
09/2016 - 04/2011
1
Ubiquitin
IBA
01/2022
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
niraparib
IBA
01/2021
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2021
1
Small Interfering RNA (siRNA)
IBA
01/2021
1
Annexin A5
IBA
01/2019
1
DAPI
IBA
01/2019
1
Fluorescein (Funduscein)
FDA Link
Generic
01/2019
1
Galactosidases
IBA
01/2019
1
Fluorescein-5-isothiocyanate (FITC)
IBA
01/2019
1
Tubulin
IBA
01/2019
1
isothiocyanic acid
IBA
01/2019
1
Deubiquitinating Enzymes
IBA
01/2018
1
Messenger RNA (mRNA)
IBA
09/2016
1
Somatomedin Receptors (Somatomedin Receptor)
IBA
01/2015
1
cixutumumab
IBA
01/2015
1
Cetuximab (Erbitux)
FDA Link
01/2015
1
Sirtuin 1
IBA
12/2014
1
Positive Transcriptional Elongation Factor B
IBA
12/2014
1
Dichlororibofuranosylbenzimidazole (DRB)
IBA
12/2014
1
src-Family Kinases
IBA
11/2012
1
Dasatinib (BMS 354825)
FDA Link
11/2012
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
04/2011
1
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
04/2011
1
Cisplatin (Platino)
FDA Link
Generic
04/2011
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
04/2011
1
Antibodies
IBA
04/2011
1
vandetanib (ZD6474)
IBA
04/2011
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2009
1
Glutathione (Reduced Glutathione)
IBA
11/2009
1
4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- one
IBA
11/2009
1
aziridine (ethyleneimine)
IBA
11/2009
Therapy/Procedure
11
Radiotherapy
01/2022 - 04/2011
3
Therapeutics
01/2022 - 04/2011
1
X-Ray Therapy
01/2017
1
Proton Therapy
01/2017
1
Particle Accelerators
10/2016
1
Aftercare (After-Treatment)
09/2016